Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)

NCT01917552 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01917552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01917552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)
Lead sponsor
Asan Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
August 19, 2013
Completion date
August 1, 2026
Enrollment
870 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer